Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Variable Interest Entities Narrative (Details)

v3.6.0.2
Acquisitions, Investments, and Licenses - Variable Interest Entities Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Jul. 09, 2015
Jun. 30, 2016
Jun. 30, 2012
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Variable Interest Entity [Line Items]              
Gain on deconsolidation of SciVac       $ 0 $ 15,940 $ 0  
Business combination, separately recognized transactions, net gains and losses       $ 2,500      
Zebra              
Variable Interest Entity [Line Items]              
Ownership percentage       28.00%      
VBI Vaccines Inc              
Variable Interest Entity [Line Items]              
Stock ownership percentage   15.00%          
Payments to acquire equity method investments   $ 5,700          
Equity method investment, number of shares purchased in period   1,362,370          
Series A Preferred Stock | Zebra              
Variable Interest Entity [Line Items]              
Investment owned, shares (in shares)       1,260,000      
Restricted Stock | Zebra              
Variable Interest Entity [Line Items]              
Investment owned, shares (in shares)       900,000      
Variable Interest Entity, Not Primary Beneficiary | Zebra              
Variable Interest Entity [Line Items]              
Ownership percentage       28.00%      
SciVac | Variable Interest Entity, Primary Beneficiary              
Variable Interest Entity [Line Items]              
Stock ownership percentage     50.00%        
Additional working capital             $ 7,900
Levon Resources Ltd              
Variable Interest Entity [Line Items]              
Stock ownership percentage 24.50%            
Cash contribution       $ 21,200      
Other Operating Income (Expense) | SciVac              
Variable Interest Entity [Line Items]              
Gain on deconsolidation of SciVac       $ 15,900